Stifel Financial Research

Stifel's recent European research indicates a bifurcated equity landscape characterized by divergent performance drivers across key sectors. While high-quality business services firms such as Experian and RS Group are demonstrating capital allocation discipline through significant share buybacks, the UK real estate sector continues to face substantial headwinds from elevated gilt yields and tightening loan-to-value metrics. Commodity-sensitive operations like Energean are contending with acute production volatility stemming from geopolitical instability in Israel. Conversely, the Medtech segment remains a bright spot, with Ypsomed and Schott Pharma benefiting from sustained demand for specialized autoinjector technology and GLP-1 containment solutions. Overall, the research highlights a pivot toward companies with robust cash flow profiles while emphasizing caution regarding interest-rate-sensitive assets.